News & Perspective

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Nov 01, 2012

Nov 01, 2012

Study: Rapid flu tests do best at high viral loads

(CIDRAP News) – Commercially available rapid influenza diagnostic tests (RIDTs) detected common virus strains at high concentrations fairly well but performed variably at lower concentrations, an evaluation of all 11 Food and Drug Administration–approved RIDTs showed.

Oct 01, 2012

Oct 01, 2012

WHO: 2013 southern flu vaccine should copy 2012 northern version

(CIDRAP News) – The World Health Organization (WHO) is recommending that influenza vaccines for the Southern Hemisphere's 2013 flu season should contain the same three strains as the vaccines now being administered to millions in the Northern Hemisphere.

Jun 11, 2012

Jun 11, 2012

Studies: Antiviral prescribing reflects CDC guidance, flu activity

(CIDRAP News) – Clinicians are heeding antiviral prescribing guidance changes made over the past decade because of antiviral resistance and a greater focus on protecting high-risk patients, particularly during the 2009 H1N1 pandemic, researchers reported today.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»